Managing the lifeline: Preemptive access management for better outcomes for hemodialysis patients and programs

Advances in Renal Replacement Therapy

Volumn 7, Issue 4 SUPPL., 2000, Pages

  Silver, M R ^a   Cain, J A ^a  

^a Renal Network Inc   (United States)

Author keywords

Arteriovenous shunts; Chronic; Hemodialysis; Kidney failure; Surgical; Vascular access

Indexed keywords

ARTERIOVENOUS FISTULA; ARTICLE; CLINICAL PRACTICE; COST BENEFIT ANALYSIS; FINANCIAL MANAGEMENT; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE QUALITY; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MORBIDITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; QUALITY CONTROL; TREATMENT OUTCOME; VASCULAR ACCESS;

ARTERIOVENOUS SHUNT, SURGICAL; BLOOD VESSEL PROSTHESIS; HEALTH PERSONNEL; HEALTH SERVICES ACCESSIBILITY; HUMAN; ILLINOIS; INDIANA; KENTUCKY; OHIO; QUALITY ASSURANCE, HEALTH CARE; REFERRAL AND CONSULTATION; RENAL DIALYSIS; SUPPORT, U.S. GOV'T, P.H.S.; TOTAL QUALITY MANAGEMENT; UNITED STATES; UNITED STATES CENTERS FOR MEDICARE AND MEDICAID SERVICES;

EID: 0033779532     PISSN: 10734449     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Hemodialysis vascular access morbidity
2. NKF DOQI Clinical Practice Guidelines for vascular access
3. Hemodialysis access failure; A call to action
4. Predictors of type of vascular access in hemodialysis patients
5. Determinants of type and timing of initial permanent hemodialysis vascular access
6. Use of standardized ratios to examine variability in hemodialysis vascular access across facilities
7. Results of arteriovenous fistula revision in the forearm
8. The use of basilic vein and brachial artery as an A-V fistula for long-term hemodialysis
9. The upper arm AV haemoaccess: Long term follow-up
10. Staged basilic vein transposition for dialysis angioaccess
11. Superior patency of perforating antecubital vein arteriovenous fistulae for hemodialysis
12. Brachiocephalic jump graft fistula: An alternative for dialysis. Use of elbow crease veins
13. Strategies to increase the use of autogenous arteriovenous fistula in end-stage renal disease
14. Salvage of the nonfunctioning arteriovenous fistula
15. Subclavian vascular access stenosis in dialysis patients: Natural history and risk factors
16. Right atrial bypass grafting for central venous obstruction associated with dialysis access; another treatment option
17. Prediction of hemodialysis synthetic graft thrombosis: Can we identify factors that impair validity of the dysfunction hypothesis?
18. Change in access blood flow over time predicts vascular access thrombosis
19. Prolongation of hemodialysis access survival with elective revision
20. Predicting hemodialysis access failure with color flow Doppler ultrasound
21. Prophylactic angioplasty reduces thrombosis in virgin ePTFE arteriovenous dialysis grafts with greater than 50% stenosis: Subset analysis of a prospectively randomized study
22. Predictive measures of vascular access thrombosis: A prospective study
23. Accuracy of decrease in blood flow in predicting hemodialysis graft thrombosis
24. Thrombotic complications resulting from hypercoagulable states in chronic hemodialysis vascular access
25. A large prospective survey of anti-cardiolipin antibodies in chronic hemodialysis patients
26. Antibodies to topical bovine thrombin correlate with access thrombosis
27. 'Antiphospholipid' antibodies developing in the setting of vascular surgery frequently result from exposure to bovine thrombin
28. Antiphospholipid antibodies in left-ventricular assist system recipients after exposure to topical bovine thrombin
29. Factors influencing arteriovenous fistula dysfunction in Japanese patients on chronic hemodialysis
30. Vascular access stenosis: Prospects for prevention and therapy
31. Effects of oral antihyperglycemic agents on extracellular matrix synthesis by mesangial cells
32. AtherosclerosisAn inflammatory disease
33. Detrimental effects of late referral in patients with chronic renal failure: A case-control study
34. Excess morbidity in patients starting uremia therapy without prior care by a nephrologist
35. Cannula thrombophlebitis: A study in volunteers comparing polytetrafluoroethylene, polyurethane, and polyamide-ether-elastomer cannulae
36. Early referral and its impact on emergent first dialyses, health care costs, and outcome
37. Influence of catheter type on occurrence of thrombophlebitis during peripheral intravenous nutrition
38. Risk factors for infusion-related phlebitis with small peripheral venous catheters. A randomized controlled trial
39. Infusion phlebitis in patients with acute pneumonia: A prospective study
40. A prospective clinical comparison of two intravenous polyurethane cannulae
41. Excessive blood drawing for laboratory tests
42. Establishing the vascular access coordinator; breaking ground for better outcomes
43. Percutaneous catheters used for vascular access are associated with increased risk of death